IT’S HEALTH LITERACY MONTH: Smarter choices. Better health. Lower healthcare costs. Join the conversation!
IT’S HEALTH LITERACY MONTH: Smarter choices. Better health. Lower healthcare costs. Join the conversation!
IT’S HEALTH LITERACY MONTH: Smarter choices. Better health. Lower healthcare costs. Join the conversation!
IT’S HEALTH LITERACY MONTH: Smarter choices. Better health. Lower healthcare costs. Join the conversation!
<div id="buzzsprout-player-18983304"></div><script src="https://www.buzzsprout.com/2117715/episodes/18983304-episode-65-helping-employees-navigate-obesity-treatments-and-health-choices-in-the-workplace-with-dr-laure-demattia.js?container_id=buzzsprout-player-18983304&player=small" type="text/javascript" charset="utf-8"></script>
Dr. Seth Serxner, PhD, MPH
In this episode of The Health Literacy 2.0 Podcast, host Seth Serxner welcomes obesity medicine expert Dr. Laure DeMattia to unpack the complexities of obesity treatment, GLP-1 medications, and the evolving landscape of health literacy.
With over two decades of experience in obesity medicine, Laure DeMattia brings both personal and professional insight to the conversation. Having lived with obesity herself, she was drawn to the field early, before it became a board-certified specialty. Her current work spans primary care within the Indian Health System and telehealth for post-bariatric surgery patients. Driven by a passion to improve patient outcomes, she advocates for individualized approaches rooted in medical science, compassion, and practical guidance.
Seth Serxner and Laure DeMattia discuss:
☑️ Understanding GLP-1s: These medications have been transformative for diabetes and obesity but require ongoing medical supervision for safety and efficacy.
☑️ Medication Mindset: Many patients hope for a quick fix, but obesity is a lifelong, relapsing condition—medications like GLP-1s are a long-term commitment, not a temporary solution.
☑️ Safety Concerns: The rise of online, gray market, and over-the-counter sales for GLP-1s poses risks of dosage inaccuracies and non-sterile products, emphasizing the importance of physician-directed treatment.
☑️ Disease vs. Willpower: Obesity is a complex, multifactorial disease—not simply a matter of willpower. Genetic predisposition plays a large role.
☑️ Beyond BMI: Reliance on BMI for diagnosis is limited; true assessment considers body composition, genetics, and clinical factors.
☑️ Social Determinants & Environment: Where you live and social factors can profoundly impact your ability to manage obesity and overall health.
☑️ Health Literacy & Advocacy: Empowering patients through health literacy, credible resources, and ongoing support helps combat misinformation and stigma.
☑️ Individualized Care: There is no one-size-fits-all. Success means finding sustainable strategies tailored to the patient's genetics, environment, and personal needs.
☑️ Pursuit of Health vs. Thinness: The goal should be strength, wellness, and self-care, not simply weight loss for appearance's sake.
The conversation highlights the need for compassionate, data-driven approaches, whether it's medication, lifestyle modification, or navigating a complex healthcare system.
Learn About EdLogics
Want to see how EdLogics' gamified platform can boost health literacy, drive engagement in health and wellness programs, and help people live happier, healthier lives?
Visit the EdLogics website: www.edlogics.com.
